FCNKX
Price
$26.78
Change
-$0.23 (-0.85%)
Updated
Aug 20 closing price
Net Assets
172.69B
RGAFX
Price
$88.15
Change
+$0.79 (+0.90%)
Updated
Aug 21 closing price
Net Assets
342.42B
Interact to see
Advertisement

FCNKX vs RGAFX

FCNKX vs RGAFX Comparison Chart in %
View a ticker or compare two or three
VS
FCNKX vs. RGAFX commentary
Aug 23, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FCNKX is a StrongBuy and RGAFX is a StrongBuy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RGAFX has more cash in the bank: 342B vs. FCNKX (173B). RGAFX pays higher dividends than FCNKX: RGAFX (0.48) vs FCNKX (0.00). FCNKX was incepted earlier than RGAFX: FCNKX (18 years) vs RGAFX (24 years). FCNKX (0.67) is less costly to investors than RGAFX (0.34). RGAFX is a more actively managed with annual turnover of: 32.00 vs. FCNKX (29.00). FCNKX has a lower initial minimum investment than RGAFX: FCNKX (0) vs RGAFX (250). FCNKX annual gain was more profitable for investors over the last year : 12.05 vs. RGAFX (5.92). FCNKX return over 5 years is better than : 39.25 vs. RGAFX (18.79).
FCNKXRGAFXFCNKX / RGAFX
Total Expense Ratio0.670.34197%
Annual Report Gross Expense Ratio0.670.34197%
Fund Existence18 years24 years-
Gain YTD9.7099.612101%
Front LoadN/AN/A-
Min. Initial Investment0250-
Min. Initial Investment IRAN/AN/A-
Net Assets173B342B51%
Annual Yield % from dividends0.000.48-
Returns for 1 year12.055.92204%
Returns for 3 years79.0348.73162%
Returns for 5 years39.2518.79209%
Returns for 10 years165.38104.75158%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
RNWFX109.531.63
+1.51%
American Funds New World R-5
CMJAX52.540.36
+0.69%
Calvert US Mid Cap Core Rspnb Idx A
SVFDX100.610.67
+0.67%
Smead Value R1
PSSMX31.230.20
+0.64%
Principal SmallCap S&P 600 Index R3
CREYX11.05N/A
N/A
Columbia Real Estate Equity Inst3